Highly concentrated aqueous protein solution with reduced viscosity
US9457089B2 · kind B2 · utility
13Cited by
2References
21Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 10, 2013 |
| Grant date | Oct 4, 2016 |
| Priority date | — |
| Expiry date | Jun 5, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In an aqueous solution, a composition includes at least one protein, including at least one antibody fragment, and at least one water-soluble viscosity-reducing agent chosen from the group consisting of cytidine, 2′-deoxycytidine, uridine, 2′-deoxyuridine, thymidine and ribothymidine, alone or as a mixture. The protein includes at least one antibody fragment being at a concentration greater than or equal to 50 mg/ml.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.